SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-05-001934
Filing Date
2005-07-14
Accepted
2005-07-14 06:41:39
Documents
7
Period of Report
2005-04-30

Document Format Files

Seq Description Document Type Size
1 peregrine_10k.htm 10-K 954733
2 GRAPHIC image001.jpg GRAPHIC 4900
3 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 1366
4 CONSENT OF ACCOUNTING FIRM ex_23-1.htm EX-23.1 2099
5 CERTIFICATION OF CEO ex_31-1.htm EX-31.1 7342
6 CERTIFICATION OF CFO ex_31-2.htm EX-31.2 6851
7 CERTIFICATION OF CEO AND CFO ex_32.htm EX-32 6292
  Complete submission text file 0001019687-05-001934.txt   987173
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 000-17085 | Film No.: 05953438
SIC: 2835 In Vitro & In Vivo Diagnostic Substances